Monogram Health valuation, funding and investors
Monogram Health works in specialty chronic condition care delivery, based in Brentwood, United States. Founded in 2019, it has about 942 employees.
- Last round
- Growth · $375M · Jan 2023
- Valuation at last round
- $3.04B · implied
- Headcount
- 942 · up
- Grade
- D
- Founded
- 2019
Monogram Health valuation today
VCMC values Monogram Health at $3.9B today, with a range of $649M to $5.6B and a grade of D. The valuation starts from its last funding round, a growth round in Jan 2023.
Valuation by date (98 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2019 | $12.4M | $4.52M – $34.1M | $15.3M (+24%) | before first round | – | unknown | D | 0% |
| 1 Feb 2019 | $12.7M | $4.64M – $35.0M | $15.5M (+21%) | before first round | – | unknown | D | 0% |
| 1 Mar 2019 | $13.1M | $4.75M – $35.9M | $15.6M (+19%) | before first round | – | unknown | D | 0% |
| 1 Apr 2019 | $13.4M | $4.88M – $36.8M | $15.7M (+17%) | before first round | – | unknown | D | 0% |
| 1 May 2019 | $13.8M | $5.01M – $37.8M | $15.9M (+15%) | before first round | – | unknown | D | 0% |
| 1 Jun 2019 | $14.1M | $5.15M – $38.8M | $16.0M (+13%) | before first round | – | unknown | D | 0% |
| 1 Jul 2019 | $14.5M | $5.28M – $39.8M | $16.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Aug 2019 | $14.7M | $5.33M – $40.2M | $16.3M (+11%) | before first round | – | unknown | D | 0% |
| 1 Sep 2019 | $14.8M | $5.38M – $40.6M | $16.5M (+11%) | before first round | – | unknown | D | 0% |
| 1 Oct 2019 | $14.9M | $5.43M – $41.0M | $16.6M (+11%) | before first round | – | unknown | D | 0% |
| 1 Nov 2019 | $15.1M | $5.48M – $41.4M | $16.8M (+11%) | before first round | – | unknown | D | 0% |
| 1 Dec 2019 | $15.2M | $5.53M – $41.7M | $16.9M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jan 2020 | $15.3M | $5.58M – $42.1M | $17.1M (+11%) | before first round | – | unknown | D | 0% |
| 1 Feb 2020 | $15.5M | $5.63M – $42.5M | $17.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Mar 2020 | $15.6M | $5.68M – $42.9M | $17.4M (+11%) | before first round | – | unknown | D | 0% |
| 1 Apr 2020 | $15.7M | $5.73M – $43.3M | $17.5M (+11%) | before first round | – | unknown | D | 0% |
| 1 May 2020 | $15.9M | $5.78M – $43.6M | $17.7M (+11%) | before first round | – | unknown | D | 0% |
| 6 May 2020 | $39.0M | $25.6M – $107M | $70.0M (+80%) | after a round | – | unknown | C | 0% |
| 1 Jun 2020 | $40.6M | $25.6M – $107M | $70.0M (+72%) | after a round | – | unknown | C | 0% |
| 1 Jul 2020 | $42.6M | $25.6M – $107M | $70.0M (+64%) | after a round | – | unknown | C | 0% |
| 1 Aug 2020 | $44.8M | $25.6M – $107M | $70.0M (+56%) | after a round | – | unknown | C | 0% |
| 1 Sep 2020 | $47.1M | $25.6M – $107M | $70.0M (+49%) | after a round | – | unknown | C | 0% |
| 1 Oct 2020 | $49.4M | $25.6M – $107M | $70.0M (+42%) | after a round | – | unknown | C | 0% |
| 1 Nov 2020 | $52.0M | $25.6M – $107M | $70.0M (+35%) | after a round | – | unknown | C | 0% |
| 1 Dec 2020 | $54.5M | $25.6M – $107M | $70.0M (+28%) | after a round | – | unknown | C | 0% |
| 1 Jan 2021 | $57.3M | $25.6M – $107M | $70.0M (+22%) | after a round | 17 | unknown | C | 0% |
| 1 Feb 2021 | $60.2M | $25.6M – $107M | $70.0M (+16%) | after a round | 17 | unknown | C | 0% |
| 1 Mar 2021 | $63.0M | $25.6M – $107M | $70.0M (+11%) | after a round | 17 | unknown | C | 0% |
| 1 Apr 2021 | $66.2M | $25.6M – $107M | $70.0M (+6%) | after a round | 17 | unknown | C | 0% |
| 1 May 2021 | $69.5M | $25.6M – $107M | $70.0M (+1%) | after a round | 17 | unknown | C | 0% |
| 1 Jun 2021 | $70.0M | $24.5M – $107M | $70.0M (0%) | after a round | 17 | unknown | C | 0% |
| 9 Jun 2021 | $471M | $331M – $1.0B | $705M (+50%) | after a round | 17 | unknown | B | 0% |
| 1 Jul 2021 | $482M | $331M – $1.0B | $705M (+46%) | after a round | 17 | unknown | B | 0% |
| 1 Aug 2021 | $499M | $331M – $1.0B | $705M (+41%) | after a round | 17 | unknown | B | 0% |
| 1 Sep 2021 | $517M | $331M – $1.0B | $705M (+36%) | after a round | 17 | unknown | B | 0% |
| 1 Oct 2021 | $534M | $331M – $1.0B | $705M (+32%) | after a round | 17 | unknown | B | 0% |
| 1 Nov 2021 | $553M | $331M – $1.0B | $705M (+28%) | after a round | 17 | unknown | B | 0% |
| 1 Dec 2021 | $572M | $331M – $1.0B | $705M (+23%) | after a round | 17 | unknown | B | 0% |
| 1 Jan 2022 | $592M | $331M – $1.0B | $705M (+19%) | after a round | 17 | unknown | B | 0% |
| 1 Feb 2022 | $613M | $331M – $1.0B | $705M (+15%) | after a round | 17 | unknown | B | 0% |
| 1 Mar 2022 | $632M | $331M – $1.0B | $705M (+12%) | after a round | 17 | unknown | B | 0% |
| 1 Apr 2022 | $987M | $550M – $1.7B | $1.2B (+19%) | after a round | 170 | growing | B | 0% |
| 1 May 2022 | $1.1B | $550M – $1.7B | $1.2B (+10%) | after a round | 170 | growing | B | 0% |
| 1 Jun 2022 | $1.1B | $550M – $1.7B | $1.2B (+2%) | after a round | 170 | growing | B | 0% |
| 1 Jul 2022 | $1.2B | $555M – $1.7B | $1.2B (0%) | after a round | 170 | growing | B | 0% |
| 1 Aug 2022 | $1.2B | $509M – $1.7B | $1.2B (0%) | after a round | 170 | unknown | B | 0% |
| 1 Sep 2022 | $1.2B | $487M – $1.7B | $1.2B (0%) | after a round | 170 | unknown | C | 0% |
| 1 Oct 2022 | $1.2B | $467M – $1.7B | $1.2B (0%) | after a round | 170 | unknown | C | 0% |
| 1 Nov 2022 | $1.2B | $447M – $1.7B | $1.2B (0%) | after a round | 170 | unknown | C | 0% |
| 1 Dec 2022 | $1.2B | $428M – $1.7B | $1.2B (0%) | after a round | 170 | unknown | C | 0% |
| 1 Jan 2023 | $1.2B | $410M – $1.7B | $1.2B (0%) | after a round | 170 | unknown | C | 0% |
| 10 Jan 2023 | $3.0B | $2.1B – $4.7B | $3.3B (+10%) | after a round | 170 | unknown | B | 0% |
| 1 Feb 2023 | $3.1B | $2.1B – $4.7B | $3.3B (+9%) | after a round | 400 | growing | B | 0% |
| 1 Mar 2023 | $3.1B | $2.1B – $4.7B | $3.3B (+9%) | after a round | 400 | growing | B | 0% |
| 1 Apr 2023 | $3.1B | $2.1B – $4.7B | $3.3B (+8%) | after a round | 400 | growing | B | 0% |
| 1 May 2023 | $3.1B | $2.1B – $4.7B | $3.3B (+7%) | after a round | 400 | growing | B | 0% |
| 1 Jun 2023 | $3.2B | $2.1B – $4.7B | $3.3B (+6%) | after a round | 400 | growing | B | 0% |
| 1 Jul 2023 | $3.2B | $2.1B – $4.7B | $3.3B (+5%) | after a round | 400 | growing | B | 0% |
| 1 Aug 2023 | $3.2B | $2.1B – $4.7B | $3.3B (+4%) | after a round | 400 | growing | B | 0% |
| 1 Sep 2023 | $3.2B | $2.1B – $4.7B | $3.3B (+3%) | after a round | 400 | growing | B | 0% |
| 1 Oct 2023 | $3.3B | $2.1B – $4.7B | $3.3B (+3%) | after a round | 400 | unknown | B | 0% |
| 1 Nov 2023 | $3.4B | $2.3B – $5.0B | $3.5B (+3%) | after a round | 500 | up | B | 0% |
| 1 Dec 2023 | $3.5B | $2.3B – $5.0B | $3.5B (+2%) | after a round | 500 | up | B | 0% |
| 1 Jan 2024 | $3.5B | $2.3B – $5.0B | $3.5B (0%) | after a round | 500 | up | B | 0% |
| 1 Feb 2024 | $3.5B | $2.2B – $5.0B | $3.5B (0%) | after a round | 500 | up | B | 0% |
| 1 Mar 2024 | $3.5B | $2.1B – $5.0B | $3.5B (0%) | after a round | 500 | up | B | 0% |
| 1 Apr 2024 | $3.6B | $2.1B – $5.0B | $3.6B (0%) | after a round | 530 | up | B | 0% |
| 1 May 2024 | $3.6B | $2.1B – $5.0B | $3.6B (0%) | after a round | 530 | up | B | 0% |
| 1 Jun 2024 | $3.6B | $2.0B – $5.0B | $3.6B (0%) | after a round | 530 | up | B | 0% |
| 1 Jul 2024 | $3.6B | $2.0B – $5.0B | $3.6B (0%) | after a round | 530 | up | B | 0% |
| 1 Aug 2024 | $3.6B | $1.6B – $5.0B | $3.6B (0%) | after a round | 530 | flat | B | 0% |
| 1 Sep 2024 | $3.6B | $1.9B – $5.2B | $3.6B (0%) | after a round | 590 | up | B | 0% |
| 1 Oct 2024 | $3.6B | $1.8B – $5.2B | $3.6B (0%) | after a round | 590 | up | B | 0% |
| 1 Nov 2024 | $3.6B | $1.8B – $5.2B | $3.6B (0%) | after a round | 590 | up | B | 0% |
| 1 Dec 2024 | $3.7B | $1.8B – $5.2B | $3.7B (0%) | after a round | 630 | up | B | 0% |
| 1 Jan 2025 | $3.7B | $1.7B – $5.2B | $3.7B (0%) | after a round | 630 | up | B | 0% |
| 1 Feb 2025 | $3.7B | $1.5B – $5.2B | $3.7B (0%) | after a round | 630 | up | C | 0% |
| 1 Mar 2025 | $3.7B | $1.5B – $5.2B | $3.7B (0%) | after a round | 630 | up | C | 0% |
| 1 Apr 2025 | $3.7B | $1.4B – $5.2B | $3.7B (0%) | after a round | 630 | up | C | 0% |
| 1 May 2025 | $3.7B | $1.4B – $5.2B | $3.6B (-1%) | after a round | 630 | up | C | 0% |
| 1 Jun 2025 | $3.7B | $1.3B – $5.2B | $3.6B (-2%) | after a round | 630 | up | C | 0% |
| 1 Jul 2025 | $3.7B | $1.3B – $5.2B | $3.6B (-2%) | after a round | 630 | up | C | 0% |
| 1 Aug 2025 | $3.7B | $1.3B – $5.2B | $3.6B (-2%) | after a round | 630 | up | C | 0% |
| 1 Sep 2025 | $3.8B | $2.0B – $5.5B | $3.8B (0%) | after a round | 757 | growing | B | 0% |
| 1 Oct 2025 | $3.8B | $1.2B – $5.5B | $3.8B (-1%) | after a round | 757 | up | C | 0% |
| 1 Nov 2025 | $3.9B | $1.9B – $5.5B | $3.9B (0%) | after a round | 799 | growing | B | 0% |
| 1 Dec 2025 | $3.9B | $1.9B – $5.5B | $3.9B (0%) | after a round | 799 | growing | B | 0% |
| 1 Jan 2026 | $3.9B | $1.9B – $5.5B | $3.9B (0%) | after a round | 810 | growing | B | 0% |
| 1 Feb 2026 | $3.9B | $1.7B – $5.5B | $3.9B (0%) | after a round | 810 | growing | B | 0% |
| 1 Mar 2026 | $3.9B | $869M – $5.5B | $3.8B (-2%) | after a round | 810 | up | C | 0% |
| 1 Apr 2026 | $3.9B | $833M – $5.5B | $3.8B (-2%) | after a round | 810 | up | C | 0% |
| 1 May 2026 | $3.9B | $799M – $5.5B | $3.8B (-2%) | after a round | 810 | up | C | 0% |
| 1 Jun 2026 | $3.9B | $779M – $5.5B | $3.7B (-5%) | after a round | 874 | up | C | 0% |
| 1 Jul 2026 | $3.9B | $748M – $5.5B | $3.7B (-5%) | after a round | 874 | up | C | 0% |
| 1 Aug 2026 | $3.9B | $722M – $5.5B | $3.7B (-4%) | after a round | 904 | up | D | 0% |
| 1 Sep 2026 | $3.9B | $692M – $5.5B | $3.7B (-4%) | after a round | 904 | up | D | 0% |
| 1 Oct 2026 | $3.9B | $670M – $5.6B | $3.8B (-3%) | after a round | 942 | up | D | 0% |
| 24 Oct 2026 | $3.9B | $649M – $5.6B | $3.8B (-3%) | after a round | 942 | up | D | 0% |
Key facts about Monogram Health
- Founded
- 2019
- Headquarters
- Brentwood, United States
- Employees
- about 942 +24% in a year
- Total raised
- $542M
- Funding rounds
- 3
- Last round
- Growth Equity Jan 2023
Monogram Health was founded in 2019 by Michael Uchrin.
Monogram Health funding history
Monogram Health has 3 funding rounds on record, from May 2020 to Jan 2023, $542M in total. None disclosed a valuation.
Growth Equity 9 Jan 2023
Led by TPG; with Frist Cressey Ventures, Heritage Group, Pura Vida, Norwest, CVS Health, The Cigna Group Ventures, Humana, Memorial Hermann Health System, SCAN.
Sources: monogramhealth.com, tpg.com, mobihealthnews.com and 3 more
$375M
Series B 8 Jun 2021
Led by TPG; with Frist Cressey Ventures, Norwest, Humana Inc..
Sources: finsmes.com, prnewswire.com, bassberry.com and 2 more
$160M
Series A 5 May 2020
Led by Frist Cressey Ventures, Norwest.
Sources: monogramhealth.com, pulse2.com, finsmes.com and 1 more
$7.0M
Monogram Health investors
11 investors have backed Monogram Health; Frist Cressey Ventures, Norwest and TPG led at least one round.
- Norwest lead, 3 rounds
- TPG lead, 2 rounds
- CVS Health
- Humana
- Humana Inc.
- Memorial Hermann Health System
- SCAN
What Monogram Health does
Monogram Health works in home health care, with 15 recorded offerings and customers in healthcare.
Monogram Health, Inc. is an American company that provides in-home specialty care and benefit management services for patients with polychronic conditions, including diabetes, hypertension, chronic kidney disease, heart failure, depression, COPD, and other metabolic disorders. The company operates a pod model that integrates clinicians, behavioral health providers, and social workers to deliver care and address social determinants of health. Monogram Health also offers medication review, education, counseling, and support for daily needs such as food, transportation, and financial assistance. The company collaborates with primary care providers and specialists to coordinate care and evidence-based treatment.
Description from Veridion's company data.
Products and services
- Specialty Chronic Condition Care Delivery
- In-Home Clinical Diagnosis and Treatment
- Medication Review and Optimization Services
- Chronic Disease Management Services
- Behavioral Health Support Services
- Palliative Care Services
- Social Determinants Support Services
- Daily Living Assistance Services
- Primary Care Coordination Services
- Multispecialty Clinical Consultation Services
- Evidence-Based Treatment Planning Services
- Patient Education and Counseling Services
- Health Outcome Improvement Services
- Medical Cost Reduction Services
- Patient Quality of Life Enhancement Services
Markets
- Healthcare
Business model
- Business-to-Consumer
- Service Provider
- Healthcare
Industry codes (NAICS)
- 621610 Home Health Care Services 100% match
Questions about Monogram Health
What is Monogram Health worth?
Valuation $3.9B (range $649M to $5.6B), as of 24 Oct 2026.
Has Monogram Health raised money?
Monogram Health has 3 funding rounds on record, from May 2020 to Jan 2023, $542M in total. None disclosed a valuation.
Who has invested in Monogram Health?
Frist Cressey Ventures, Norwest, TPG, CVS Health, Heritage Group and Humana, and 5 more. Lead investors include Frist Cressey Ventures, Norwest and TPG.
How many people work at Monogram Health?
About 942, up 24% over the last year. Headcount grew from 17 in Jan 2021 to 942 in Sep 2026.
What does Monogram Health do?
Monogram Health works in home health care, with 15 recorded offerings and customers in healthcare. Its main offerings are specialty chronic condition care delivery, in-home clinical diagnosis and treatment and medication review and optimization services.
When was Monogram Health founded, and where is it based?
Monogram Health was founded in 2019 and is based in Brentwood, United States. It has about 942 employees, up 24% over the last year.